Related references
Note: Only part of the references are listed.ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease
T. Kucharzik et al.
JOURNAL OF CROHNS & COLITIS (2021)
Incidence and risk factors of Pneumocystis jirovecii pneumonia in Korean patients with inflammatory bowel disease
Kwangwoo Nam et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Clinical Characteristics and Risk Factors for Pneumocystis Jirovecii Pneumonia during Immunosuppressive Treatment in Patients with Ulcerative Colitis: A Retrospective Study
Kentaro Kojima et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2020)
Risk factors for mortality from pneumocystis carinii pneumonia (PCP) in non-HIV patients: a meta-analysis
Yao Liu et al.
ONCOTARGET (2017)
Pneumocystis jirovecii pneumonia in pediatric Inflammatory Bowel Disease: a Case Report and Literature Review
Sally J. Lawrence et al.
FRONTIERS IN PEDIATRICS (2017)
Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression
Thomas G. Cotter et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Fungal Infections and New Biologic Therapies
Snigdha Vallabhaneni et al.
CURRENT RHEUMATOLOGY REPORTS (2016)
Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014
L. Cooley et al.
INTERNAL MEDICINE JOURNAL (2014)
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
J. F. Rahier et al.
JOURNAL OF CROHNS & COLITIS (2014)
Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients
Anat Stern et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Increased Risk of Pneumonia Among Patients With Inflammatory Bowel Disease
Millie D. Long et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/OAG) (AWMF 055/066)
J. Thoden et al.
INFECTION (2013)
Pneumocystis Jiroveci Pneumonia in Patients with Inflammatory Bowel Disease: A Survey of Prophylaxis Patterns Among Gastroenterology Providers
Philip N. Okafor et al.
INFLAMMATORY BOWEL DISEASES (2013)
Pneumocystis Jiroveci Pneumonia in Inflammatory Bowel Disease: When Should Prophylaxis be Considered?
Philip N. Okafor et al.
INFLAMMATORY BOWEL DISEASES (2013)
Epidemiology and Natural History of Inflammatory Bowel Diseases
Jacques Cosnes et al.
GASTROENTEROLOGY (2011)
Pneumocystis jirovecii colonization and infection among non HIV-infected patients
F. Fily et al.
MEDECINE ET MALADIES INFECTIEUSES (2011)
Pneumocystis pneumonia associated with infliximab in Japan
Masayoshi Harigai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients:: Systematic review and meta-analysis of randomized controlled trials
Hefziba Green et al.
MAYO CLINIC PROCEEDINGS (2007)
Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy:: A review of 84 cases
Nirmal Kaur et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: A retrospective study 2002-2004
Ulrik M. Overgaard et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2007)
An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital
LJ Worth et al.
BRITISH JOURNAL OF CANCER (2005)
Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-α therapy with infliximab for Crohn's disease
FS Velayos et al.
INFLAMMATORY BOWEL DISEASES (2004)
Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients
M Rodriguez et al.
CLINICAL MICROBIOLOGY REVIEWS (2004)
Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy:: a prospective study
NA Maskell et al.
THORAX (2003)
Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients
F Roblot et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2002)
Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome
KA Sepkowitz
CLINICAL INFECTIOUS DISEASES (2002)
Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995 - Comparison of HIV-associated cases to other immunocompromised states
NG Mansharamani et al.
CHEST (2000)
Share Paper
